RxDoctor Payments Data

Scott Trimas, MD

Plastic Surgery within the Head & Neck · Jacksonville, FLNPI 1881784841

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Merz North America, Inc. at 41.8% of the total. Reporting peaked in 2022 at $931 and has fallen 55.0% since, to $419 in 2025.

$3,054in general payments, 2019–2025

Across 105 payments — averaging $29.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merz North America, Inc.$1K
  • AbbVie$797
  • Integra Lifesciences Corporation$171
  • Galderma Laboratories, L.p.$120
  • Musculoskeletal Transplant Foundation Inc.$107
  • Optinose US, Inc.$94
  • plus $487 from 14 others

What the payments were for

  • Food & beverage$3,054100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,054 in reported general payments places this provider in the 65th percentile of 50 plastic surgery within the head & neck providers in Florida.

See all plastic surgery within the head & neck providers in Florida

Medicare billing

Part B allowed, 2024
$1,509,628
Medicare patients
146
Services billed
1,487

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tobramycin-DexamethasoneTobramycin/Dexamethasone32$832
Cephalexin126$320
ErythromycinErythromycin Base34$305
Mupirocin17$189
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen30$165
Methylprednisolone24$122
Promethazine Hcl25$108

Paid to pharmacies, not to this prescriber.

Other plastic surgery within the head & neck in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →